Cantor Fitzgerald Weighs in on Actinium Pharmaceuticals, Inc.’s FY2024 Earnings (NYSEAMERICAN:ATNM)

Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Cantor Fitzgerald raised their FY2024 earnings estimates for Actinium Pharmaceuticals in a report released on Monday, April 1st. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will earn ($1.84) per share for the year, up from their previous estimate of ($2.14). Cantor Fitzgerald currently […]

Leave a Reply

Your email address will not be published.

Previous post Red Sox hit five home runs to beat Angels 8-6, Trevor Story to undergo MRI
Next post PVH Corp. Expected to Earn Q1 2025 Earnings of $2.15 Per Share (NYSE:PVH)